Seoul National University Hospital ( Site 0191)

Seoul 03080

1 studies enrolling now · 2 studies all time

What they study most

Advanced Solid Tumors, Urothelial Carcinoma

Studies at this site

• A Study of Calderasib (MK-1084) in KRAS Mutant Advanced Solid Tumors (MK-1084-001) — Recruiting now
• Study of First-line Pembrolizumab (MK-3475) With Lenvatinib (MK-7902/E7080) in Urothelial Carcinoma Cisplatin-ineligible Participants Whose Tumors Express Programmed Cell Death-Ligand 1 and in Participants Ineligible for Platinum-containing Chemotherapy (MK-7902-011/E7080-G000-317/ LEAP-011) — Completed